Astrazeneca (AZN) Liabilities from Discontinued Operations (2011)

Astrazeneca (AZN) recorded quarterly Liabilities from Discontinued Operations of 196000000.0 in Q2 2011.

Astrazeneca (AZN) Liabilities from Discontinued Operations (2011) Analysis & Trends

Astrazeneca's Liabilities from Discontinued Operations history runs 1 years deep, the most recent figure standing at 196000000.0 for Q2 2011.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn
10	Astrazeneca	72.15 Bn	64.21 Bn	12.61 Bn

Download Data

Date	Value
Jun 30, 2011	-196.00 Mn
Jun 30, 2011	-196.00 Mn